Scheimpflug camera useful as no-history method for determining corneal power in post-LASIK eyes
August 15th 2008Images from a rotating Scheimpflug camera (Pentacam, Oculus) provide less accurate information on corneal power in post-LASIK eyes than methods involving adjustment based on the amount of laser correction, but the imaging device represents a useful tool when clinical history data are not available, according to the results of a retrospective study.
Optical coherence tomography a useful addition to clinical practice, doctor finds
August 15th 2008A proprietary device for optical coherence tomography (Visante, Carl Zeiss Meditec) seems to be a highly useful addition to clinical practice. The instrument, according to one physician, may be the best resource thus far to evaluate placement of intracorneal segments, femtosecond laser-enabled keratoplasty, and penetrating keratoplasty.
Confocal microscopy yields higher-resolution images
August 15th 2008Confocal microscopy can be used for refractive surgery to address concerns regarding wound healing and the interface, especially when assessing different techniques. The technology also can be used to assess problems after LASIK regarding dry eye.
Manual and automated iris boundary detection provide accurate methodology for ablation centration
August 15th 2008A recent study assessed the consistency and repeatability of skilled refractive surgeons in detecting the iris boundary from the infrared camera of a proprietary excimer laser (STAR S4 IR, Advanced Medical Optics) and used as a gold standard for evaluating the platform's automated system. Results show that both methods provide a level of centration accuracy consistent with quality vision results.
A new view on imaging the anterior segment
August 15th 2008A new version of an ophthalmic ultrasound system has the unique ability to image all aspects of the anterior segment. As a key differentiator to optical coherence tomography, the ultrasound system, which has a high-frequency B-probe, enables the user to see behind the iris and create dynamic movies rather than static images.
Automated system separates glaucomatous, healthy eyes
August 15th 2008An automated glaucoma risk indicator using digital color fundus photos proved to be accurate in the detection of glaucoma disease in a recent study. This novel technique is not intended to replace other state-of-the-art diagnostic techniques currently used . Ophthalmologists, however, can receive a confirmation from this automated diagnosing system that the diagnosis they are making in regards to glaucoma is the right one.
Screening not foolproof for avoiding post-LASIK ectasia
August 15th 2008Several preoperative features have been identified as important risk factors for ectasia after laser refractive surgery, particularly in patients undergoing LASIK for high myopia or myopic astigmatism. This complication can occur in the absence of any of these findings, however.
Patient presents with unilateral blurred vision
August 15th 2008A 50-year-old Haitian-born woman preÂsented to the Bascom Palmer Eye Institute with a complaint of suddenly decreased vision in her right eye over the previous 4 days. The patient denied other symptoms of pain, redness, photophobia, floaters, or photopsias.
Surface ablation yields excellent outcomes with buttonholes
August 15th 2008Patients desiring laser vision correction are treated with phototherapeutic kertectomy and PRK with mitomycin-C either simultaneously or in a staged approach depending on the absence or presence of epithelial ingrowth. A retrospective review of 15 eyes that developed a buttonhole or near buttonhole during LASIK flap creation shows favorable visual outcomes can be achieved.
Network seeks to provide DNA samples for eye disease
August 1st 2008The National Ophthalmic Disease Genotyping Network (eyeGENE), developed in 2007 by the National Eye Institute, is a repository of inherited eye disease DNA samples that can be used anonymously for research. The hope is that eyeGENE will facilitate discovery of new ophthalmic disease genes, help researchers identify genetic modifiers of disease, and enhance patient enrollment in clinical trials.
Ranibizumab benefits those with macular edema due to retinal vein occlusion
August 1st 2008Three monthly injections of ranibizumab, 0.3 and 0.5 mg, appear to provide benefit to patients with macular edema due to central retinal vein occlusion or branch retinal vein occlusion. Foveal thickness decreased significantly with both doses, and there was a concomitant increase in the visual acuity. Most patients require more than three injections to maintain the benefit. The average duration of treatment and the final visual outcomes are not yet known.
Systemic neuroprotectin D1 is a potent inhibitor of laser-induced choroidal neovascularization
August 1st 2008The neuroprotectin D1 (NPD1) molecule showed potential as a therapy for neovascular age-related macular degeneration in a recent study. Lesion leakage and lesion diameter were both significantly reduced following administration of NPD1 in a mouse model of laser-induced choroidal neovascularization.
Pegaptanib shows promise as adjunct to progressive diabetic retinopathy treatment
August 1st 2008Pegaptanib sodium (Macugen, [OSI] Eyetech/Pfizer) used as an adjunct to laser therapy has a significant impact in the treatment of patients with progressive diabetic retinopathy, offering much hope for the prognosis of patients who have this disorder.
Innovation takes center stage at Association for Research in Vision and Ophthalmology 2008 meeting
August 1st 2008The focus was on innovation at this year's annual meeting of the Association for Research in Vision and Ophthalmology. Among the highlights were the latest developments in the areas of retinal disease, allergy, dry eye, and lid margin disease.